DENTSPLY SIRONA Inc.

For the period ended Jun 30, 2026. Filed Aug 6, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 6, 2026

XRAY$9.54+0.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations

(in millions, except per share amounts)

	Three Months Ended June 30,		Six Months Ended June 30,
	2026	2025	2026	2025
Net sales	$898	$936	$1,778	$1,815
Cost of products sold	405	446	858	859
Gross profit	493	490	920	956
Selling, general, and administrative expenses	364	342	715	700
Research and development expenses	45	37	89	73
Goodwill and intangible asset impairments	—	235	—	235
Restructuring and other costs	2	4	69	13
Operating income (loss)	82	(128)	47	(65)
Other income and expenses:
Interest expense, net	22	24	46	43
Other (income) expense, net	(12)	1	(29)	1
Income (loss) before income taxes	72	(153)	30	(109)
Provision (benefit) for income taxes	36	(109)	4	(84)
Net income (loss)	36	(44)	26	(25)
Less: Net (loss) income attributable to noncontrolling interest	(1)	1	(1)	—
Net income (loss) attributable to Dentsply Sirona	$37	$(45)	$27	$(25)
Earnings (loss) per common share attributable to Dentsply Sirona:
Basic	$0.18	$(0.22)	$0.14	$(0.13)
Diluted	$0.18	$(0.22)	$0.14	$(0.13)
Weighted average common shares outstanding:
Basic	199.7	199.3	199.8	199.2
Diluted	200.5	199.3	200.8	199.2

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.